Loading clinical trials...
Loading clinical trials...
Effect of Add-on L-Arginine Therapy on Clinical Outcome of Heart Failure Patients: A Randomized- Controlled Trial
Heart failure is considered one of the greatest challenges globally. There are various treatment strategies for heart failure. L-Arginine is an amino acid that was found to have beneficial effect on vasculature. This study aims to study the benefits and side effects of using L-arginine on the patients with ejection fraction \<40%
Age
19 - No limit years
Sex
ALL
Healthy Volunteers
No
Ain Shams University
Cairo, Egypt
Start Date
February 1, 2026
Primary Completion Date
March 1, 2027
Completion Date
July 1, 2027
Last Updated
February 6, 2026
200
ESTIMATED participants
L-Arginine Powder
DRUG
Placebo
DRUG
Lead Sponsor
German University in Cairo
Collaborators
NCT07191730
NCT07484009
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions